Embo Medical developed the first one-shot peripheral vascular embolization device, the Caterpillar; a unique platform technology for use in the field of embolization; a minimally invasive procedure to deliberately and permanently stop blood flow in a blood vessel. The Embo platform technology provides a superior solution in shorter procedural times; resulting in safe, cost-effective embolization.

The Founders developed the concept and technology as part of the Bioinnovate Ireland Fellowship.

ACT was an early stage investor in the project with co-investors Enterprise Equity, WDC, Enterprise Ireland and private investors.

Embo was acquired by CR Bard (NYSE:BCR).